Literature DB >> 25754289

A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence.

Claudi L Bockting1, Steven D Hollon2, Robin B Jarrett3, Willem Kuyken4, Keith Dobson5.   

Abstract

Major depressive disorder (MDD) is highly disabling and typically runs a recurrent course. Knowledge about prevention of relapse and recurrence is crucial to the long-term welfare of people who suffer from this disorder. This article provides an overview of the current evidence for the prevention of relapse and recurrence using psychological interventions. We first describe a conceptual framework to preventive interventions based on: acute treatment; continuation treatment, or; prevention strategies for patients in remission. In brief, cognitive-behavioral interventions, delivered during the acute phase, appear to have an enduring effect that protects patients against relapse and perhaps others from recurrence following treatment termination. Similarly, continuation treatment with either cognitive therapy or perhaps interpersonal psychotherapy appears to reduce risk for relapse and maintenance treatment appears to reduce risk for recurrence. Preventive relapse strategies like preventive cognitive therapy or mindfulness based cognitive therapy (MBCT) applied to patients in remission protects against subsequent relapse and perhaps recurrence. There is some preliminary evidence of specific mediation via changing the content or the process of cognition. Continuation CT and preventive interventions started after remission (CBT, MBCT) seem to have the largest differential effects for individuals that need them the most. Those who have the greatest risk for relapse and recurrence including patients with unstable remission, more previous episodes, potentially childhood trauma, early age of onset. These prescriptive indications, if confirmed in future research, may point the way to personalizing prevention strategies. Doing so, may maximize the efficiency with which they are applied and have the potential to target the mechanisms that appear to underlie these effects. This may help make this prevention strategies more efficacious.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depression; Prevention; Psychological intervention; Recurrence; Relapse

Mesh:

Year:  2015        PMID: 25754289     DOI: 10.1016/j.cpr.2015.02.003

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  57 in total

1.  Differential role of CBT skills, DBT skills and psychological flexibility in predicting depressive versus anxiety symptom improvement.

Authors:  Christian A Webb; Courtney Beard; Sarah J Kertz; Kean J Hsu; Thröstur Björgvinsson
Journal:  Behav Res Ther       Date:  2016-03-30

Review 2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.

Authors:  Raymond W Lam; Diane McIntosh; JianLi Wang; Murray W Enns; Theo Kolivakis; Erin E Michalak; Jitender Sareen; Wei-Yi Song; Sidney H Kennedy; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

3.  Can we help more?

Authors:  Robin B Jarrett
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

4.  Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.

Authors:  Tina Pahlevan; Christine Ung; Zindel Segal
Journal:  Can J Psychiatry       Date:  2020-02-07       Impact factor: 4.356

5.  Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial.

Authors:  Ali Ghaleiha; Hassan Davari; Leila Jahangard; Mohammad Haghighi; Mohammad Ahmadpanah; Mohammad Ali Seifrabie; Hafez Bajoghli; Edith Holsboer-Trachsler; Serge Brand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-03-16       Impact factor: 5.270

Review 6.  Depression and Depressive Symptoms in Pediatric Traumatic Brain Injury: A Scoping Review.

Authors:  Christianne Laliberté Durish; Rosemary S Pereverseff; Keith O Yeates
Journal:  J Head Trauma Rehabil       Date:  2018 May/Jun       Impact factor: 2.710

7.  Childhood Adversities and Depression in Adulthood: Current Findings and Future Directions.

Authors:  Richard T Liu
Journal:  Clin Psychol (New York)       Date:  2017-03-23

8.  Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.

Authors:  Amanda J Shallcross; Emily C Willroth; Aaron Fisher; Sona Dimidjian; James J Gross; Pallavi D Visvanathan; Iris B Mauss
Journal:  Behav Ther       Date:  2018-02-08

Review 9.  Mindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxis.

Authors:  Zindel V Segal; Kathleen M Walsh
Journal:  Curr Opin Psychiatry       Date:  2016-01       Impact factor: 4.741

10.  Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing care.

Authors:  Robin B Jarrett; Abu Minhajuddin; Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase
Journal:  J Consult Clin Psychol       Date:  2015-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.